ES2174632T3 - Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales. - Google Patents
Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales.Info
- Publication number
- ES2174632T3 ES2174632T3 ES99939844T ES99939844T ES2174632T3 ES 2174632 T3 ES2174632 T3 ES 2174632T3 ES 99939844 T ES99939844 T ES 99939844T ES 99939844 T ES99939844 T ES 99939844T ES 2174632 T3 ES2174632 T3 ES 2174632T3
- Authority
- ES
- Spain
- Prior art keywords
- alkyl
- radical
- alkylcarbonylamino
- halo
- optionally substituted
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 229940126601 medicinal product Drugs 0.000 title 1
- 125000000753 cycloalkyl group Chemical group 0.000 abstract 9
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract 3
- ZHNUHDYFZUAESO-UHFFFAOYSA-N Formamide Chemical class NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 abstract 2
- 125000003545 alkoxy group Chemical group 0.000 abstract 2
- 125000003806 alkyl carbonyl amino group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- 125000004663 dialkyl amino group Chemical group 0.000 abstract 2
- -1 format Chemical group 0.000 abstract 2
- 150000004820 halides Chemical group 0.000 abstract 2
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 2
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 1
- 125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
- 125000003282 alkyl amino group Chemical group 0.000 abstract 1
- 125000004448 alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005196 alkyl carbonyloxy group Chemical group 0.000 abstract 1
- 125000004414 alkyl thio group Chemical group 0.000 abstract 1
- 125000005140 aralkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005126 aryl alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000005099 aryl alkyl carbonyl group Chemical group 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 125000004659 aryl alkyl thio group Chemical group 0.000 abstract 1
- 125000002102 aryl alkyloxo group Chemical group 0.000 abstract 1
- 125000004658 aryl carbonyl amino group Chemical group 0.000 abstract 1
- 125000005129 aryl carbonyl group Chemical group 0.000 abstract 1
- 125000005199 aryl carbonyloxy group Chemical group 0.000 abstract 1
- 125000003118 aryl group Chemical group 0.000 abstract 1
- 125000005161 aryl oxy carbonyl group Chemical group 0.000 abstract 1
- 125000004391 aryl sulfonyl group Chemical group 0.000 abstract 1
- 125000005110 aryl thio group Chemical group 0.000 abstract 1
- 125000004104 aryloxy group Chemical group 0.000 abstract 1
- 125000004429 atom Chemical group 0.000 abstract 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract 1
- 125000003917 carbamoyl group Chemical class [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 125000004093 cyano group Chemical group *C#N 0.000 abstract 1
- 125000000000 cycloalkoxy group Chemical group 0.000 abstract 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 abstract 1
- 125000005201 cycloalkylcarbonyloxy group Chemical group 0.000 abstract 1
- 125000005144 cycloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005366 cycloalkylthio group Chemical group 0.000 abstract 1
- 125000004985 dialkyl amino alkyl group Chemical group 0.000 abstract 1
- 125000004986 diarylamino group Chemical group 0.000 abstract 1
- 125000002485 formyl group Chemical group [H]C(*)=O 0.000 abstract 1
- 125000005221 halo alkyl carbonyl amino group Chemical group 0.000 abstract 1
- 125000004993 haloalkoxycarbonyl group Chemical group 0.000 abstract 1
- 125000004692 haloalkylcarbonyl group Chemical group 0.000 abstract 1
- 125000005203 haloalkylcarbonyloxy group Chemical group 0.000 abstract 1
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 abstract 1
- 125000005843 halogen group Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- BLNWTAHYTCHDJH-UHFFFAOYSA-O hydroxy(oxo)azanium Chemical compound O[NH+]=O BLNWTAHYTCHDJH-UHFFFAOYSA-O 0.000 abstract 1
- 125000002768 hydroxyalkyl group Chemical group 0.000 abstract 1
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
- 229910052760 oxygen Inorganic materials 0.000 abstract 1
- 239000001301 oxygen Substances 0.000 abstract 1
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 125000004076 pyridyl group Chemical group 0.000 abstract 1
- 229910052717 sulfur Inorganic materials 0.000 abstract 1
- 125000004434 sulfur atom Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/18—Feminine contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Anesthesiology (AREA)
- Gynecology & Obstetrics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
Derivados de fórmula general Ia (Ia¿ y Ia¿¿): en las que R2 representa un hidroxilo o un radical alcoxi (C1-C6), R3 representa un átomo de hidrógeno o un radical alquil, siendo R6 un radical alquil, opcionalmente sustituido por alquil, haluro, amino, grupos alquiloxi, alquiloxicarbonil, un grupo fenil o piridil opcionalmente sustituido por un grupo alquil, haluro, nitro, dialquilamino, alquiloxi, alquiloxicarbonil, alquilamino, X representa preferentemente un radical divalente de fórmula R11 representa preferentemente un átomo de oxígeno o un átomo de azufre, R14 y R15 representan, independientemente uno de otro, un átomo de hidrógeno, un radical alquil (C1-C6), un cicloalquil (C3-C6), halo alquil (C1-C6), perhaloalquil (C1- C6), aril, aralquil, alcoxi (C1-C6), cicloalcoxi (C3-C6), mono o polihaloalcoxi, ariloxi, aralquiloxi, hidroxialquil, alquiloxialquil, alquiltio (C1-C6), cicloalquiltio (C3-C6), mono o polihaloalquiltio, ariltio, aralquiltio, formato, alquilcarboniloxi (C1-C6), un cicloalquilcarboniloxi (C3-C6), haloalquilcarboniloxi (C1-C3), arilcarboniloxi, aralquilcarboniloxi, dialquilaminoalquil, dialquilamino, diarilamino, diaralquilamino, carboxamida opcionalmente sustituída, formamida, un alquilcarbonilamino (C1-C6), un cicloalquilcarbonilamino (C3-C6), halo alquilcarbonilamino (C1-C6), perhalo alquilcarbonilamino (C1-C6), arilcarbonilamino (C3-C6), aralquilcarbonilamino (C1-C6), formil, un alquilcarbonil (C1-C6), un cicloalquilcarbonil (C3-C6), haloalquilcarbonil (C1-C6), perhaloalquilcarbonil (C1-C6), arilcarbonil, aralquilcarbonil, carboxil, alcoxicarbonil (C1-C6), cicloalcoxicarbonil (C3-C6), haloalcoxicarbonil, ariloxicarbonil, aralquiloxicarbonil, un alquilsulfonil (C1-C6), un cicloalquilsulfonil (C3-C6), haloalquilsulfonil (C1-C6), perhaloalquilsulfonil (C1-C6), arilsulfonil, aralquilsulfonil, radical halo, ciano o nitro.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/042,990 US6048868A (en) | 1994-09-14 | 1998-03-17 | Melatonin-antagonist β-carboline derivatives and analogues thereof containing naphthalenic structure, process for their preparation and their use as medicinal products |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2174632T3 true ES2174632T3 (es) | 2002-11-01 |
Family
ID=21924862
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES99939844T Expired - Lifetime ES2174632T3 (es) | 1998-03-17 | 1999-03-17 | Derivados de beta-carbolina hipnotica, procedimiento para su preparacion y su utilizacion como productos medicinales. |
Country Status (24)
| Country | Link |
|---|---|
| EP (1) | EP1064284B1 (es) |
| JP (1) | JP4333036B2 (es) |
| CN (1) | CN1115342C (es) |
| AR (1) | AR018767A1 (es) |
| AT (1) | ATE215087T1 (es) |
| AU (1) | AU752364B2 (es) |
| BG (1) | BG63973B1 (es) |
| BR (1) | BR9908833A (es) |
| CA (1) | CA2324270A1 (es) |
| DE (1) | DE69901098T2 (es) |
| DK (1) | DK1064284T3 (es) |
| ES (1) | ES2174632T3 (es) |
| HU (1) | HUP0101234A3 (es) |
| IL (1) | IL138442A (es) |
| IS (1) | IS2199B (es) |
| NO (1) | NO317296B1 (es) |
| NZ (1) | NZ506913A (es) |
| PL (1) | PL193450B1 (es) |
| PT (1) | PT1064284E (es) |
| RU (1) | RU2210571C2 (es) |
| SK (1) | SK284387B6 (es) |
| TR (1) | TR200003596T2 (es) |
| UA (1) | UA71911C2 (es) |
| WO (1) | WO1999047521A1 (es) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2824829B1 (fr) * | 2001-05-16 | 2005-06-03 | Macef | Nouveaux derives de dihydroimidazo [5,1-a]-beta-carboline, leur procede de preparation et leur application a titre de medicament |
| FR2904973A1 (fr) * | 2006-08-18 | 2008-02-22 | Fourtillan Snc | Derives de 1-methylidene-pyrido[3,4-b]indole et leur utilisation en therapeutique. |
| FR2916200A1 (fr) * | 2007-05-18 | 2008-11-21 | Fourtillan Snc | Nouveaux derives des 1,2,3,4,6,7,12,12a-octahydro pyrazino[1',2':1,6]pyrido[3,4-b]indoles, leur preparation et leur utilisation en therapeutique |
| CA2727055C (en) | 2008-01-11 | 2016-12-20 | Albany Molecular Research, Inc. | (1-azinone) -substituted pyridoindoles as mch antagonists |
| WO2011003005A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azepino[b]indole and pyrido-pyrrolo-azepine mch-1 antagonists, methods of making, and use thereof |
| US8629158B2 (en) | 2009-07-01 | 2014-01-14 | Albany Molecular Research, Inc. | Azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine MCH-1 antagonists, methods of making, and use thereof |
| WO2011003012A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azapolycycle mch-1 antagonists, methods of making, and use thereof |
| WO2011003021A1 (en) | 2009-07-01 | 2011-01-06 | Albany Molecular Research, Inc. | Azinone-substituted azabicycloalkane-indole and azabicycloalkane-pyrrolo-pyridine mch-1 antagonists, methods of making, and use thereof |
| WO2012088124A2 (en) | 2010-12-21 | 2012-06-28 | Albany Molecular Research, Inc. | Tetrahydro-azacarboline mch-1 antagonists, methods of making, and uses thereof |
| US8697700B2 (en) | 2010-12-21 | 2014-04-15 | Albany Molecular Research, Inc. | Piperazinone-substituted tetrahydro-carboline MCH-1 antagonists, methods of making, and uses thereof |
| FI130627B (en) * | 2021-03-31 | 2023-12-18 | Equinorm Ltd | Novel heterocyclic compounds and their use |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5283343A (en) * | 1987-08-17 | 1994-02-01 | Whitby Research, Inc. | 2-aryl substituted N-acetyltryptamines and process of preparing such |
| HU207070B (en) * | 1990-10-31 | 1993-03-01 | Richter Gedeon Vegyeszet | Process for producing 1beta-ethyl-1alpha-hydroxymethyl-1,2,3,4,6,712,12balpha-octahydroindolo(2,3-a) quinolizine |
| RU2067980C1 (ru) * | 1992-06-30 | 1996-10-20 | Глэксо Груп Лимитед | Производные лактама и фармацевтическая композиция, являющаяся антагонистом 5-окситраптамина /5-нт/ на 5- нт3 -рецепторах или их физиологически приемлемые соли и соловаты |
| RU2068847C1 (ru) * | 1994-05-18 | 1996-11-10 | Всероссийский научный центр по безопасности биологически активных веществ | ПРОИЗВОДНЫЕ 3,4-ДИГИДРО- ИЛИ 1,2,3,4-ТЕТРАГИДРО- β -КАРБОЛИНОВ ИЛИ ИХ СОЛИ С ОРГАНИЧЕСКИМИ ИЛИ НЕОРГАНИЧЕСКИМИ КИСЛОТАМИ, ПРОЯВЛЯЮЩИЕ АНТИМИКРОБНУЮ АКТИВНОСТЬ |
| FR2724384B1 (fr) * | 1994-09-14 | 1999-04-16 | Cemaf | Nouveaux derives de la 3,4-dihydro beta-carboline agonistes de la melatonine, leur procede de preparation et leur utilisation a titre de medicament |
-
1999
- 1999-03-17 BR BR9908833-9A patent/BR9908833A/pt not_active Application Discontinuation
- 1999-03-17 TR TR2000/03596T patent/TR200003596T2/xx unknown
- 1999-03-17 AU AU32707/99A patent/AU752364B2/en not_active Ceased
- 1999-03-17 PL PL99342929A patent/PL193450B1/pl not_active IP Right Cessation
- 1999-03-17 EP EP99939844A patent/EP1064284B1/en not_active Expired - Lifetime
- 1999-03-17 RU RU2000126288/04A patent/RU2210571C2/ru not_active IP Right Cessation
- 1999-03-17 ES ES99939844T patent/ES2174632T3/es not_active Expired - Lifetime
- 1999-03-17 IL IL138442A patent/IL138442A/en not_active IP Right Cessation
- 1999-03-17 NZ NZ506913A patent/NZ506913A/en unknown
- 1999-03-17 CN CN99805687A patent/CN1115342C/zh not_active Expired - Fee Related
- 1999-03-17 UA UA2000105839A patent/UA71911C2/uk unknown
- 1999-03-17 AT AT99939844T patent/ATE215087T1/de not_active IP Right Cessation
- 1999-03-17 DK DK99939844T patent/DK1064284T3/da active
- 1999-03-17 AR ARP990101166A patent/AR018767A1/es active IP Right Grant
- 1999-03-17 WO PCT/IB1999/000494 patent/WO1999047521A1/en not_active Ceased
- 1999-03-17 JP JP2000536716A patent/JP4333036B2/ja not_active Expired - Fee Related
- 1999-03-17 SK SK1385-2000A patent/SK284387B6/sk not_active IP Right Cessation
- 1999-03-17 DE DE69901098T patent/DE69901098T2/de not_active Expired - Lifetime
- 1999-03-17 PT PT99939844T patent/PT1064284E/pt unknown
- 1999-03-17 CA CA002324270A patent/CA2324270A1/en not_active Abandoned
- 1999-03-17 HU HU0101234A patent/HUP0101234A3/hu unknown
-
2000
- 2000-09-12 IS IS5627A patent/IS2199B/is unknown
- 2000-09-14 BG BG104768A patent/BG63973B1/bg unknown
- 2000-09-15 NO NO20004638A patent/NO317296B1/no not_active IP Right Cessation
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AR015770A1 (es) | DERIVADOS DE ÁCIDO PIRIDIN-3-CARBOXíLICO uTILES COMO INTERMEDIARIOS EN LA PREPARACIoN DE PIRAZOLO PIRIMIDINONAS. | |
| DK146488D0 (da) | Pyrazolderivater, fremgangsmaade til fremstilling af samme og herbicidesammensaetninger indeholdende disse | |
| HUT48242A (en) | Process for producing 2-//piperidin-4-yl/-methyl/-1,2,3,4-tetrahydro9h-pyrido/3,4-b/indol derivatives and pharmaceutical compositions containing them | |
| CO5031287A1 (es) | 1 arilpirazoles planguicidas racion y metodo de represion empleando dicha composicion | |
| GR3036830T3 (en) | Pyrazole derivatives, method for preparing same, and pharmaceutical compositions containing said derivatives | |
| AR036042A1 (es) | Derivados aralquilsufonil-3-(pirrol-2-ilmetiliden)-2-indolinona, sus composiciones farmaceuticas y metodo para la modulacion de la actividad catalitica de una proteina quinasa | |
| AR076259A2 (es) | Derivados de 3,5-dietil-1h-pirazol-4-il-oxi nitrilos, composiciones farmaceuticas que los contienen y uso de los mismos en el tratamiento de infecciones por hiv | |
| CO6230985A2 (es) | Herbicidas de n-oxido piridina sustituida | |
| CO6270320A2 (es) | Derivados de piperidina utiles como antagonistas del receptor orexina | |
| EA200970493A1 (ru) | Макроциклические ингибиторы вируса гепатита с | |
| AR067327A1 (es) | Derivados de piperidina / piperazina | |
| ES2531149T3 (es) | Derivados de 2-piridiniletilcarboxamida y su uso como fungicidas | |
| PL327466A1 (en) | Novel derivatives of barbituric acid, method of obtaining them and pharmaceutic agents containing such compounds | |
| BG104287A (en) | Halogensubstituted tetracyclic derivatives of tetrahydrofuran | |
| CO4920225A1 (es) | 2-amino-6-(4-fenoxi-2-sustituido)-piridinas sustituidas | |
| AR049418A1 (es) | Derivados de heteroarilaminopirazol y composiciones farmaceuticas para el tratamiento de la diabetes. | |
| MXPA02012073A (es) | 2-(cianoamino)pirimidinas substituidas con 5-fenilo fungicidas. | |
| ATE163921T1 (de) | Azoxycyanbenzol-derivate | |
| AR083861A1 (es) | OXAZOLIDINONAS COMO MODULADORES DE mGluR5 Y COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN | |
| AR018767A1 (es) | Derivados de beta-carbolina hipnoticos, proceso para su preparacion y medicamentos | |
| MXPA06001039A (es) | Derivados de nicotinamida utiles como inhibidores de pde4. | |
| MX2007003872A (es) | Nuevos derivados bis-azaindolicos, preparacion y su uso farmaceutico de los mismos como inhibidores de cinasas. | |
| EA200400867A2 (ru) | Новые соединения гетероциклического оксима, способ их получения и фармацевтические композиции, содержащие их | |
| AR062113A1 (es) | Derivados de eteres heterociclicos sustituidos,composiciones farmaceuticas que los contienen y usos en trastornos del cns. | |
| CO5080793A1 (es) | Productos derivados de las sulfonamidas |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 1064284 Country of ref document: ES |